| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 07/09/2009 | US20090176704 treating Type II diabetes, eating disorders, and insulin-resistance syndrome with exendin peptide analogs of given amino acid sequence |
| 07/09/2009 | US20090176703 Neuropeptides for aquatic organisms culture |
| 07/09/2009 | US20090176702 Use of long-acting recombinant human soluble tumor necrosis factor alpha receptor in manufacture of a medicament for the treatment and/or prophylaxis of hepatic failure |
| 07/09/2009 | US20090176701 Anti-microbial agents that interact with the complement system |
| 07/09/2009 | US20090176700 Derivatives Of GLP-1 Analogs |
| 07/09/2009 | US20090176699 Inhibitors Based on Fusion, Hr1 and Hr2 Sequences in Bacterial Adhesin |
| 07/09/2009 | US20090176698 Benzimidazolone Derivatives for the Treatment of Urinary Incontinence |
| 07/09/2009 | US20090176697 Method to obtain the human Chorionic Gonadotropin (hCG)/cyclodextrin complex for oral administration, product obtained by this method and clinical and therapeutic use of the complex human Chorionic Gonadotropin (hCG)/cyclodextrin |
| 07/09/2009 | US20090176696 Methods And Compositions For Modulating An Immune Response |
| 07/09/2009 | US20090176695 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176694 Reagents and Methods for Smooth Muscle Therapies |
| 07/09/2009 | US20090176693 Agent for maintaining the hardness of tooth structure |
| 07/09/2009 | US20090176692 Amidated insulin glargine |
| 07/09/2009 | US20090176691 Pharmaceutical Compositions Containing at Least One Protein Active Ingredient Protected From Digestive Enzymes |
| 07/09/2009 | US20090176279 Bioreactive agents |
| 07/09/2009 | US20090176276 Fusion Polypeptides of Human Serum Albumin and a Therapeutically Active Polypeptide |
| 07/09/2009 | US20090176254 Mammalian galanin receptors |
| 07/09/2009 | US20090175981 Compositions, methods and uses for a novel family of peptides |
| 07/09/2009 | US20090175961 Dietary Supplement Compositions |
| 07/09/2009 | US20090175946 Use of gelatin and a cross-linking agent for producing cross-linking medical glues |
| 07/09/2009 | US20090175943 Transdiscal administration of specific inhibitors of pro-inflammatory cytokines |
| 07/09/2009 | US20090175931 Compositions and methods for modulating hemostasis |
| 07/09/2009 | US20090175910 Modifications of HIV Env, Gag, and Pol enhance immunogenicity for genetic immunization |
| 07/09/2009 | US20090175908 Influenza Hemagglutinin And Neuraminidase Variants |
| 07/09/2009 | US20090175894 Methods and materials for producing a generic anti-amyloid immune response in mammals |
| 07/09/2009 | US20090175893 Albumin-Fused Anti-Angiogenesis Peptides |
| 07/09/2009 | US20090175888 Methods of treating cancer with an antibody-drug conjugate |
| 07/09/2009 | US20090175876 Methods of using phhla2 to co-stimulate t-cells |
| 07/09/2009 | US20090175874 Novel interleukin-1 receptor intracellular ligand proteins and inhibitors of ligand binding |
| 07/09/2009 | US20090175873 Inhibiting tumor cell invasion, metastasis and angiogenesis |
| 07/09/2009 | US20090175872 Treatment of Conditions Involving Demyelination |
| 07/09/2009 | US20090175870 Ykl-40 monoclonal authority |
| 07/09/2009 | US20090175868 IGF-IR antagonists as adjuvants for treatment of prostate cancer |
| 07/09/2009 | US20090175859 TNFalpha antagonists and methotrexate in the treatment of TNF-mediated disease |
| 07/09/2009 | US20090175855 Novel compositions and methods for the treatment of immune related diseases |
| 07/09/2009 | US20090175853 Method for treating amyloid disease |
| 07/09/2009 | US20090175850 NOGO Receptor Homologs |
| 07/09/2009 | US20090175846 Oligodendrocyte-Myelin Glycoprotein Compositions and Methods of Use Thereof |
| 07/09/2009 | US20090175844 Method of diagnosing bladder cancer |
| 07/09/2009 | US20090175843 Composition for prevention or treatment of urinary tract infection |
| 07/09/2009 | US20090175842 Dietary anti-bacterial compositions |
| 07/09/2009 | US20090175841 Compounds for Improving Nutritional Status, Cognition and Survival |
| 07/09/2009 | US20090175840 Insulin formulations for insulin release as a function of tissue glucose levels |
| 07/09/2009 | US20090175839 Proteins with an attached short peptide of acidic amino acids |
| 07/09/2009 | US20090175836 Prelamin a pre peptide as a universal stem cell differentiation signal |
| 07/09/2009 | US20090175828 Coagulation Factor X Polypeptides With Modified Activation Properties |
| 07/09/2009 | US20090175825 Interferon alpha and antisense k-ras rna combination gene therapy |
| 07/09/2009 | US20090175824 Peptides for the treatment of HCV infections |
| 07/09/2009 | US20090175823 Method of treating autoimmune diseases with interferon-beta and il-2r antagonist |
| 07/09/2009 | US20090175822 C5-substituted, proline-derived, macrocyclic hepatitis c serine protease inhibitors |
| 07/09/2009 | US20090175821 Modified therapeutic peptides with extended half-lives in vivo |
| 07/09/2009 | US20090175820 Inhibitors of cytochrome p450 |
| 07/09/2009 | US20090175819 Molecule and chimeric molecules thereof |
| 07/09/2009 | US20090175808 Composition and uses thereof |
| 07/09/2009 | US20090175798 Mycobacterial Catalase-Peroxidase in the Diagnosis and Treatment of Sarcoidosis |
| 07/09/2009 | US20090175797 Inflammation-Inhibitory Serum Factors and Uses Thereof |
| 07/09/2009 | US20090175795 Chimeric therapeutic agents |
| 07/09/2009 | US20090175785 Self-Assembled Fmoc-Ff Hydrogels |
| 07/09/2009 | CA2711187A1 Pharmaceutical compositions comprising granules of purified microbial lipase and methods for preventing or treating digestive disorders |
| 07/09/2009 | CA2710920A1 Anti-proliferative compounds and their use |
| 07/09/2009 | CA2710762A1 Recombinant vwf formulations |
| 07/09/2009 | CA2710382A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2710375A1 Treatment of orthopedic conditions |
| 07/09/2009 | CA2709899A1 Pharmaceutical compositions containing at least one proteinaceous active ingredient protected against digestive enzymes |
| 07/09/2009 | CA2709781A1 Counter-pressure filtration of proteins |
| 07/09/2009 | CA2709545A1 Topical application and formulation of erythropoietin for skin wound healing |
| 07/09/2009 | CA2708549A1 Bmp mutants with decreased susceptibility to noggin |
| 07/09/2009 | CA2708538A1 Topical compositions containing desthiobiotin and its derivatives and a method of treating skin |
| 07/09/2009 | CA2701991A1 Cyclic peptides comprising at least one aza-.beta.3-aminoacyl residue and uses thereof |
| 07/08/2009 | EP2077328A1 Platelet aggregation inhibitor composition |
| 07/08/2009 | EP2077279A1 Thymic stromal lymphopoietin receptor molecules and uses thereof |
| 07/08/2009 | EP2077278A1 Peptide derived from neurotensin receptor 3 and use in the treatment of psychiatric disorders |
| 07/08/2009 | EP2077277A1 Use of mammalian cytokine; related reagents |
| 07/08/2009 | EP2077276A1 Compositions and methods for the diagnosis and treatment of disorders involving angiogensis |
| 07/08/2009 | EP2077275A2 IgA nephropathy-related DNA |
| 07/08/2009 | EP2077274A1 Synthetic analogs of human beta-defensins having antimicrobial, antiviral and chemotactic activity |
| 07/08/2009 | EP2077266A1 2-pyridinecarboxamide derivative having gk-activating activity |
| 07/08/2009 | EP2077120A2 Rheumatoid arthritis remedy containing il-6 antagonist as active ingredient |
| 07/08/2009 | EP2077119A1 Treatment of fibrosis and liver diseases |
| 07/08/2009 | EP2077118A1 Clottable concentrate of platelet growth factors and preparation method thereof |
| 07/08/2009 | EP2077117A1 Agent exhibiting immunoregulatory properties and the use thereof for treating autoimmune diseases |
| 07/08/2009 | EP2077116A1 Use of interleukin-11 as therapeutic agent for heart disease |
| 07/08/2009 | EP2077113A1 Treatment of autoimmune diseases |
| 07/08/2009 | EP2076596A1 Novel peptides for treating and preventing immune-related disorders, including treating and preventing infection by modulating innate immunity |
| 07/08/2009 | EP2076589A1 A method of producing native components, such as growth factors or extracellular matrix proteins, through cell culturing of tissue samples for tissue repair |
| 07/08/2009 | EP2076534A1 Peptides with high affinity for the prolactin receptor |
| 07/08/2009 | EP2076533A2 Modified interferon beta polypeptides and their uses |
| 07/08/2009 | EP2076529A1 Antibacterial and antiviral peptides from actinomadura namibiensis |
| 07/08/2009 | EP2076290A1 Multimeric tie 2 agonists and uses thereof in stimulating angiogenesis |
| 07/08/2009 | EP2076279A2 Native (telopeptide) placental collagen compositions |
| 07/08/2009 | EP2076278A2 Hcv ns3 protease inhibitors |
| 07/08/2009 | EP2076277A2 Method of treating or preventing tissue deterioration, injury or damage due to periodontal disease or disease of oral mucosa, and/or downregulating nf-kappab or suppressing nf-kappab-mediated actions |
| 07/08/2009 | EP2076276A2 Sol-gel materials for cellular modulation |
| 07/08/2009 | EP2076275A2 Methods and compositions useful for diabetic wound healing |
| 07/08/2009 | EP2076272A2 Generating an immune response by inducing cd40 and pattern recognition receptors |
| 07/08/2009 | EP2076257A2 Polymeric conjugates containing positively-charged moieties |
| 07/08/2009 | EP2076243A1 Liquid formulation of g-csf |
| 07/08/2009 | EP2076242A2 Aerosolizable formulation comprising insulin for pulmonary delivery |
| 07/08/2009 | EP2076140A1 Product, suitable to be given to the human body for its protective effects and health benefits, based on cow buffalo's milk self-enriched with lactoferrin, or pure lactoferrin, obtained through membrane separative processes |
| 07/08/2009 | EP2076136A2 A method of increasing retention, survival and proliferation of transplanted cells in vivo |